‘Very disappointing’: UTI pharmacy prescribing pilot extended indefinitely The Queensland UTI prescription pilot will carry on despite extensive concerns raised by doctors’ groups, including the RACGP.
‘Serious concerns’: RACGP criticises pharmacy pain trial Issues related to fragmentation and the quality of care provided were highlighted in a detailed college submission to the MSAC.
In Practice: What are the drivers of antidepressant prescribing? GPs have been invited to provide input on supporting best practice antidepressant prescribing behaviours in upcoming online focus groups.
Pharmacy pilot a ‘solution’ that would only cause bigger problems The facts simply do not support a narrative being promoted by vested interests who would be the only ones to benefit from pharmacy prescribing, according to RACGP leadership.
RACGP opposes changes to the Poisons Standard The proposed down-scheduling of budesonide and topical hydroxypinacolone retinoate poses a danger to patients, the college says.
Extension to subsidised SMS e-scripts ‘needs long-term plan’ The SMS fees will continue to be reimbursed until September, but some GPs are concerned about the uncertainty once the current extension expires.
Semaglutide shortage prompts caution around off-label prescribing GPs are being asked to prioritise the drug for people with diabetes, but with supplies critically low, what are the alternatives?
Doctors respond to leaked pharmacy UTI report A leaked evaluation of the Queensland UTI prescribing pilot reportedly indicates nearly two thirds of participants were not followed up.
Queensland Health and Pharmacy Guild stonewall queries about UTI pilot evaluation Mystery and confusion surround who has seen the report, when it was completed and if the full results will ever be publicly released.
AMAQ survey cites ‘alarming’ complications from pharmacy pilot At least 239 patients have had complications after seeing a pharmacist involved in the Queensland UTI prescribing trial, according to a new report.